NLS Research

Uncategorized - April 7, 2022

Elicera published scientific article describing the mechanism-of-action of iTANK

Elicera Therapeutics have announced the publication of a scientific article describing the mechanism-of-action of the company’s universal CAR T-cell enhancement technology platform iTANK in Nature Biomedical Engineering. Proof-of-concept data presented in the publication also indicate that the iTANK-platform is universally compatible with other CAR T-cell therapies, states the company in a press release. The iTANK-platform […]

Global report - March 25, 2022

NLS Insight: Circadian rhythms

This weekend most countries in Europe will spring forward one hour. We take a closer look upon how our inner clock regulates critical functions like behavior, hormone levels, sleep, body temperature and metabolism. Daylight Saving Time (DST) is not removed in 2022 despite the fact that the European Parliament voted to end daylight saving time […]

Uncategorized - March 21, 2022

Study reveals new genetic risk factors for migraine

The largest genetic study of migraine to date reveals new genetic risk factors. In the largest genome study of migraine yet, researchers have more than tripled the number of known genetic risk factors for migraine. Among the identified 123 genetic regions are two that contain target genes of recently developed migraine-specific drugs. The study involved […]

Uncategorized - March 16, 2022

New platform for automated cell type identification

Researchers at FIMM have developed a computational approach that can automatically identify various cell types based on single-cell RNA-sequencing data. The method has a huge potential for unbiased profiling of mixtures of cells, both for large-scale projects and samples derived from a single patient, states the researchers. It is not yet known how many different […]

Uncategorized - March 9, 2022

Asgard Therapeutics reaches major milestone

Asgard Therapeutics has reached an important milestone in the development of its lead gene therapy product, TrojanDC, a cancer immunotherapy based in cell reprogramming. Through research, the founders of the company have increased the efficiency of their reprogramming methodology approximately 190-fold, allowing efficient conversion of multiple human cell-types into dendritic cells (DCs) able to set […]

Uncategorized - March 4, 2022

Certain RNA molecules control the repair of damaged DNA in cancer cells

A new study from Karolinska Institutet shows how certain RNA molecules control the repair of damaged DNA in cancer cells, a discovery that could eventually give rise to better cancer treatments. New research demonstrates that RNA molecules have a much broader function than previously thought and can play a key role in the development of […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.